Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis

Clinical Immunology

Volumn 150, Issue 2, 2014, Pages 184-191

  Doi, Hiroyoshi ^b   Tanoue, Shiroh ^b   Kaplan, David E ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anergy; B cell; CD21; Hepatitis C; Human; Lymphocyte

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD27 ANTIGEN; CD40 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL EXPANSION; CELL LOSS; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HUMAN; IMMUNOGLOBULIN PRODUCTION; LIVER CIRRHOSIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; YOUNG ADULT;

ANERGY; B-CELL; CD21; HEPATITIS C; HUMAN; LYMPHOCYTE;

ADULT; AGED; ANTIBODY FORMATION; ANTIGENS, CD27; B-LYMPHOCYTE SUBSETS; FEMALE; HEPATITIS C; HUMANS; IMMUNOPHENOTYPING; LIVER CIRRHOSIS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PHENOTYPE; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, COMPLEMENT 3D; YOUNG ADULT;

EID: 84892465329     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.12.001     Document Type: Article

References (44)

1. Alter M.J. Epidemiology of hepatitis C virus infection. World J. Gastroenterol. 2007, 13:2436-2441.
2. Seeff L.B. Natural history of chronic hepatitis C. Hepatology 2002, 36:S35-S46.
3. Musset L., Lunel F., Cacoub P., Mannant P.R., Silvain C., Lacombe C., Opolon P., et al. Increased serum immunoglobulin G1 levels in hepatitis C virus infection. Hepatology 1995, 21:1755-1757.
4. Gonzalez-Quintela A., Alende M.R., Gamallo R., Gonzalez-Gil P., Lopez-Ben S., Tome S., Otero E., et al. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease. Hepatogastroenterology 2003, 50:2121-2126.
5. Carbonari M., Caprini E., Tedesco T., Mazzetta F., Tocco V., Casato M., Russo G., et al. Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis. J. Immunol. 2005, 174:6532-6539.
6. Charles E.D., Green R.M., Marukian S., Talal A.H., Lake-Bakaar G.V., Jacobson I.M., Rice C.M., et al. Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. Blood 2008, 111:1344-1356.
7. Ni J., Hembrador E., Di Bisceglie A.M., Jacobson I.M., Talal A.H., Butera D., Rice C.M., et al. Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients. J. Immunol. 2003, 170:3429-3439.
8. Racanelli V., Frassanito M.A., Leone P., Galiano M., De Re V., Silvestris F., Dammacco F. Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules. J. Virol. 2006, 80:3923-3934.
9. Oliviero B., Cerino A., Varchetta S., Paudice E., Pai S., Ludovisi S., Zaramella M., et al. Enhanced B cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections. J. Hepatol. 2011, 55(1):53-60.
10. Mizuochi T., Ito M., Saito K., Kasai M., Kunimura T., Morohoshi T., Momose H., et al. Possible recruitment of peripheral blood CXCR3+ CD27+ CD19+ B cells to the liver of chronic hepatitis C patients. J. Interferon Cytokine Res. 2010, 30:243-252.
11. Mizuochi T., Ito M., Takai K., Yamaguchi K. Peripheral blood memory B cells are resistant to apoptosis in chronic hepatitis C patients. Virus Res. 2011, 155:349-351.
12. Sugalski J.M., Rodriguez B., Moir S., Anthony D.D. Peripheral blood B cell subset skewing is associated with altered cell cycling and intrinsic resistance to apoptosis and reflects a state of immune activation in chronic hepatitis C virus infection. J. Immunol. 2010, 185:3019-3027.
13. Doi H., Iyer T.K., Carpenter E., Li H., Chang K.M., Vonderheide R.H., Kaplan D.E. Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population. Hepatology 2012, 55:709-719.
14. Moir S., Malaspina A., Pickeral O.K., Donoghue E.T., Vasquez J., Miller N.J., Krishnan S.R., et al. Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J. Exp. Med. 2004, 200:587-599.
15. Moir S., Ho J., Malaspina A., Wang W., DiPoto A.C., O'Shea M.A., Roby G., et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J. Exp. Med. 2008, 205:1797-1805.
16. Rakhmanov M., Keller B., Gutenberger S., Foerster C., Hoenig M., Driessen G., van der Burg M., et al. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:13451-13456.
17. Charles E.D., Brunetti C., Marukian S., Ritola K.D., Talal A.H., Marks K., Jacobson I.M., et al. Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B cell subset. Blood 2011, 117:5425-5437.
18. Rudge E.U., Cutler A.J., Pritchard N.R., Smith K.G. Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and Fc gamma RII-mediated B cell suppression. J. Exp. Med. 2002, 195:1079-1085.
19. van der Vuurst de Vries A.R., Clevers H., Logtenberg T., Meyaard L. Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is differentially expressed during human B cell differentiation and inhibits B cell receptor-mediated signaling. Eur. J. Immunol. 1999, 29:3160-3167.
20. Meyaard L. The inhibitory collagen receptor LAIR-1 (CD305). J. Leukoc. Biol. 2008, 83:799-803.
21. Wu H.J., Bondada S. CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function. J. Clin. Immunol. 2009, 29:12-21.
22. Silva R., Moir S., Kardava L., Debell K., Simhadri V.R., Ferrando-Martinez S., Leal M., et al. CD300a is expressed on human B cells, modulates BCR mediated signaling and its expression is down-regulated in HIV infection. Blood 2011, 117(22):5870-5880.
23. Bruix J., Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011, 53:1020-1022.
24. Nitschke L., Tsubata T. Molecular interactions regulate BCR signal inhibition by CD22 and CD72. Trends Immunol. 2004, 25:543-550.
25. Kaplan D.E., Sugimoto K., Ikeda F., Stadanlick J., Valiga M., Shetty K., Reddy K.R., et al. T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C. Hepatology 2005, 41:1365-1375.
26. Propst-Graham K.L., Preheim L.C., Vander Top E.A., Snitily M.U., Gentry-Nielsen M.J., et al. Cirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniae. BMC Microbiol 2007, 7:94.
27. Baumann M., Witzke O., Canbay A., Patschan S., Treichel U., Gerken G., Philipp T., et al. Serum C3 complement concentrations correlate with liver function in patients with liver cirrhosis. Hepatogastroenterology 2004, 51:1451-1453.
28. Carey W., Pimentel R., Westveer M.K., Vogt D., Broughan T. Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial. Am. J. Gastroenterol. 1990, 85:1590-1592.
29. Chalasani N., Smallwood G., Halcomb J., Fried M.W., Boyer T.D. Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation?. Liver Transplant. Surg. 1998, 4:128-132.
30. Horlander J.C., Boyle N., Manam R., Schenk M., Herring S., Kwo P.Y., Lumeng L., et al. Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation. Am. J. Med. Sci. 1999, 318:304-307.
31. McCashland T.M., Preheim L.C., Gentry M.J. Pneumococcal vaccine response in cirrhosis and liver transplantation. J. Infect. Dis. 2000, 181:757-760.
32. Fogli M., Torti C., Malacarne F., Fiorentini S., Albani M., Izzo I., Giagulli C., et al. Emergence of exhausted B cells in asymptomatic HIV-1-infected patients naive for HAART is related to reduced immune surveillance. Clin. Dev. Immunol. 2012, 2012:829584.
33. Sciaranghella G., Tong N., Mahan A.E., Suscovich T.J., Alter G. Decoupling activation and exhaustion of B cells in spontaneous controllers of HIV infection. AIDS 2013, 27:175-180.
34. Visentini M., Cagliuso M., Conti V., Carbonari M., Cibati M., Siciliano G., Cristofoletti C., et al. Clonal B cells of HCV-associated mixed cryoglobulinemia patients contain exhausted marginal zone-like and CD21 low cells overexpressing Stra13. Eur. J. Immunol. 2012, 42:1468-1476.
35. Holz L.E., Yoon J.C., Raghuraman S., Moir S., Sneller M.C., Rehermann B. B cell homeostasis in chronic hepatitis C virus-related mixed cryoglobulinemia is maintained through naive B cell apoptosis. Hepatology 2012, 56:1602-1610.
36. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., Kazzaz Z., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006, 12:1365-1371.
37. Balagopal A., Philp F.H., Astemborski J., Block T.M., Mehta A., Long R., Kirk G.D., et al. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology 2008, 135:226-233.
38. Terrier B., Joly F., Vazquez T., Benech P., Rosenzwajg M., Carpentier W., Garrido M., et al. Expansion of functionally anergic CD21-/low marginal zone-like B cell clones in hepatitis C virus infection-related autoimmunity. J. Immunol. 2011, 187:6550-6563.
39. -/low B cells in Sjogren's syndrome-associated lymphoproliferation. Arthritis Rheum. 2013, 65:1085-1096.
40. Haxhinasto S.A., Bishop G.A. Synergistic B cell activation by CD40 and the B cell antigen receptor: role of B lymphocyte antigen receptor-mediated kinase activation and tumor necrosis factor receptor-associated factor regulation. J. Biol. Chem. 2004, 279:2575-2582.
41. Boeglin E., Smulski C.R., Brun S., Milosevic S., Schneider P., Fournel S. Toll-like receptor agonists synergize with CD40L to induce either proliferation or plasma cell differentiation of mouse B cells. PLoS ONE 2011, 6:e25542.
42. Wehr C., Eibel H., Masilamani M., Illges H., Schlesier M., Peter H.H., Warnatz K. A new CD21low B cell population in the peripheral blood of patients with SLE. Clin. Immunol. 2004, 113:161-171.
43. Kremlitzka M., Polgar A., Fulop L., Kiss E., Poor G., Erdei A. Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients. Int. Immunol. 2013, 25:25-33.
44. Vergani D., Gregorio G.V., Choudhuri K., Ma Y., Vegnente A., Mieli-Vergani G. Hepatitis virus induced autoimmunity. Acta Gastroenterol. Belg. 1998, 61:217-218.